Novartis to pay $245 mln to end antitrust cases over Exforge drug generics | Reuters
Contemporary Structures | OpenStax Intro to Business
25 Years of Small-Molecule Optimization at Novartis: A Retrospective Analysis of Chemical Series Evolution | Journal of Chemical Information and Modeling
Novartis Org Chart | PDF | Novartis | Business Process